Posted by on April 30, 2018 11:54 am
Categories: Crispr Articles

Source: CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences

With news of the US Supreme Court’s recent Oil States decision and the UK’s ratification of the Unified Patent Court Agreement capturing the headlines in recent days, patent professionals might be forgiven for allowing a crucial CRISPR-Cas9 dispute to slip under the radar. But they would be wrong to do so.

Published at Mon, 30 Apr 2018 11:43:00 +0000

Leave a Reply